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Abstract
Background: Observational studies and meta-analyses relating milk consumption by adults to all-cause mortality,
coronary heart disease and stroke have obtained contradictory results. Some studies found a protective effect of
milk consumption, whilst other found an increased risk.
Methods: We performed a systematic literature search until June 2015 on prospective studies that looked at milk
consumption, all-cause mortality, coronary heart disease and stroke. Random-effect meta-analyses were performed
with dose-response.
Results: Twenty-one studies involving 19 cohorts were included in this meta-analysis, 11 on all-cause mortality, 9
on coronary heart disease, and 10 on stroke. Milk intake ranged from 0 to 850 mL/d. The summary relative risk (SRR)
for 200 mL/d milk consumption was 1.01 (95% CI: 0.96–1.06) for all-cause mortality, 1.01 (95% CI: 0.98–1.05) for fatal
and non fatal coronary heart disease, and 0.91 (95% CI: 0.82–1.02) for fatal and non fatal stroke. Stratified analyses
by age, Body Mass Index, total energy intake and physical acitivity did not alter the SRR estimates. The possibility of
publication bias was found for all cause mortality and for stroke, indicating a gap in data that could have suggested
a higher risk of these conditions with increased milk consumption.
Conclusions: We found no evidence for a decreased or increased risk of all-cause mortality, coronary heart disease,
and stroke associated with adult milk consumption. However, the possibility cannot be dismissed that risks
associated with milk consumption could be underestimated because of publication bias.
Background
Milk consumption is recommended by many nutritional
guidelines for meeting daily requirements for calcium,
animal proteins and vitamin B12 intake. In the United-
States, the national dietary guidelines recommend that
adults should drink three cups or 732 mL/d of milk [1].
Such level of consumption is, however, rarely observed.
According to the Canadian Dairy Information Centre
[2], the mean per capita milk consumption in 2014 in
the United States was 196 mL/d, in Europe 171 mL/d,
with great heterogeneity in consumption ranging from
236 mL/d in Sweden, 171 mL/d in Italy to less than
60 mL/d in Bulgaria.
Despite of its positive image, some nutritionists question
the place of cow’s milk in human nutrition in view of its
high energetic content, i.e., 83 kcal and 149 kcal for one
cup non fat milk and whole milk, respectively [3]. More-
over, whole milk is rich in saturated and transfatty acids [4].
Despite the fat content of whole milk, a meta-analysis
of prospective studies published in 2011 found that the
consumption of 200 mL/d of milk was associated with a
statistically significant 6% reduction in the risk of cardio-
vascular disease (summary relative risk [SRR] 0.94; 95%
CI: 0.89–0.99) [5]. The SRR for all-cause mortality was
0.99 (95% CI: 0.95–1.03). In contrast, a large Swedish
prospective study published in 2014 found that 200 mL/
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d of milk intake was associated with a relative risk for
cardiovascular mortality of 1.15 (95% CI: 1.12–1.19) in
women and 1.05 (95% CI: 1.03–1.07) in men [6]. More-
over the most adjusted relative risk for all-cause mortal-
ity was 1.15 (95% CI: 1.13–1.17) in women and 1.03
(95% CI: 1.01–1.04) in men, for an average milk con-
sumption of 200 mL/d [6]. This heterogeneity in results
is less present in meta-analyses for dairy products in
general. The most recent meta-analysis found an overall
SRR of 0.88 (95% CI: 0.81–0.96) with an I2 of 30% for
dairy consumption and cardiovascular diseases [7].
In view of these contradictory results observed for
milk consumption only, and knowing that since 2010
eight prospective studies have been newly published, we
performed an updated meta-analysis in order to clarify
reasons underlying these contradicting results, limiting
the analysis to milk consumption, without inclusion of
dairy products.
Method
Literature search and study selection
A systematic search and quantitative analysis was planned,
conducted and reported following PRISMA guidelines
regarding meta-analysis of observational studies [8].
Published reports until 30/06/2015 were retrieved
from Embase, Web of Science, and PubMed using
MesH index terms “milk” OR “dairy”, combined with
“mortality”, OR “coronary heart disease”, OR “stroke”.
Hand searches in reference lists of retrieved articles and of
other systematic reviews were also performed. Studies
were eligible for inclusion in our meta-analysis if they had
a prospective design, and if results related to milk intake
only were reported, irrespective of the type of milk and
not in association with any other dairy product. Because
we were willing to estimate a dose-response relationship,
milk intake had to be reported in three categories or more.
Titles were screened to exclude studies in animals,
studies in children and in sick people. In a second step,
abstracts of the articles were screened for the inclusion
criteria. For selected articles, full texts were retrieved
and fully read by at least two co-authors.
Data extraction
Milk intake data as well as most adjusted relative risks
with 95% confidence interval were extracted from selected
articles. The article selection and data extraction processes
were done by two independent reviewers. If for the same
study, several articles had been published on the same
exposure and outcome, only the most recent publication
was retained. Data extraction also involved key study
characteristics including the stratified analyses that had
been done and the possible confounders that were ad-
justed for. The selected outcomes were all-cause mortality,
fatal and non fatal coronary heart disease and fatal and
non fatal stroke.
Some studies reported results on cardiovascular diseases
[6, 9–14]. However, a careful reading of articles highlighted
that conditions encapsulated by the term “cardiovascular
diseases” were quite variable across studies, from cardio-
vascular mortality [10] to the full range of ICD-10
codes corresponding to cardiovascular diseases [6]. We
therefore decided to not perform a meta-analysis on
outcomes labelled as fatal and non fatal cardiovascular
disease occurrence.
For Mann et al. [15], the death rate ratios were con-
verted to risk ratios, and for Abbott et al. [16], cumula-
tive incidences from a figure were converted in risk
ratios and supposed expressed for quartiles of milk in-
take. For Larsson et al. [17], Goldbohm et al. [13] and
Hu et al. [18], fixed-effect meta-analyses were done
using risk estimates for whole milk and low-fat milk in
order to obtain a single relative risk for milk. For Gold-
bohm et al. [13], a second fixed-effect meta-analysis was
done using sex-specific risk estimates in order to obtain
a single relative risk for both sexes. From this last publi-
cation, risk estimates prevalent cases for non fermented
milk were extracted, because risk estimates for total milk
included also fermented milk. The articles by Appleby
et al. [19], Hu et al. [18], Iso et al. [20], and Al Delaimy
et al. [21] did not report results on milk intake and
mortality, coronary heart disease and stroke. However,
relevant data from these studies were reported in
Soedamah-Muthu et al. [5].
Statistical analysis
Milk consumption was converted from servings or other
units into mL/d by using standard conversions from the
Food Standards Agency [22]. One serving or glass of
milk was estimated to equate to 200 mL on average [22].
The dose-response meta-analysis was carried out in
programming language R (version 2.13.1, GNU General
Public License, 2011). For dose-response analysis, a first
linear model was fitted, within each study, to estimate
the relative risk per one unit of drink increase. When
the number of subjects at each category of exposure was
reported, the model was fitted according to the method
proposed by Greenland et al. [23] which provides the
natural logarithm of relative risk, and an estimator of its
standard error, taking into account the fact that the
estimates for separate categories depend on the same
reference group [23].
All statistical tests were two-sided with significance level
at 0.05. Forest plots were drawn for the relation between
milk and all-cause mortality, coronary heart disease, and
stroke.
Between-study heterogeneity across studies included
in the random-effect meta-analysis was evaluated by I2,
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which represents the percentage of total variation across
studies that is attributable to heterogeneity rather than
to chance [24]. To investigate sources of heterogeneity,
separate analyses were performed for studies adjusted
for age, Body Mass Index (BMI), total energy intake and
physical activity.
Statistically significant results are more likely to be
easily and quickly published in international peer-
reviewed journals. Null or non-significant results are
harder to publish. This has to be taken into account
in meta-analyses because this may introduce publication
bias. Publication bias was assessed using the Macaskill test
[25], the Egger test [26], the Begg test [27] and funnel plots
for all-cause mortality, coronary heart disease and stroke.
Sensitivity analyses were carried out to evaluate the influ-
ence of individual studies with major deviating results (i.e.,
Michaëlsson et al. [6] and Hu et al. [18]) and for studies
with data extracted from figures (i.e., Abbott et al. [16]).
Results
We included 21 studies in our meta-analysis, involv-
ing 19 cohorts (Fig. 1 and Additional file 1: Table S1)
[6, 9, 10, 12–21, 28–35]. We included one study pub-
lished in 1984 [16] that was not included in the meta-
analysis of Soedamah-Muthu et al. [5] We excluded five
studies selected by Soedamah-Muthu et al. [5] because of
absence of data specific to milk consumption [36, 37] or
data were about dairy products and not about milk alone
[11, 38, 39]. Engberink et al. [37], that was included in the
meta-analysis of Soedamah-Muthu et al. [5], was a
poster presentation on the Rotterdam Study that did
not report risk estimates for milk consumption. Re-
sults of the Rotterdam study on milk consumption
and stroke or coronary heart disease were published
by Praagman et al. [33], which we included in this
meta-analysis. We exluded Elwood et al. [40] for
stroke and ischemic heart disease because it was a
subsample of Elwood et al. [9]; Mann et al. [15] for
coronary heart disease because it was a duplicate of
Appleby et al. [19]; Whiteman et al. [41] for all-cause
mortality and ischemic heart disease because no quan-
tity of milk consumption was reported for these out-
comes. We could not include Avalos et al. [42] and
Snowdon et al. [43] in the meta-analysis because out-
comes were reported in two categories, which pre-
cludes a dose-response analysis.
Five cohorts were conducted in the United States, two
in Asia, 11 in Europe, and one in Australia (Additional
file 1: Table S1). The age range of study participants at
cohort inception was 34 to 74 years. Mean (SD) cohort
follow-up was 16 (5) years. We categorised the cohorts
according to outcomes (Additional file 1: Table S1): 11
cohorts including 281,788 subjects reported on 63,545
all-cause deaths, nine cohorts including 403,776 sujects
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Fig. 1 Prisma flow chart of selections of studies included in the meta-analyses relating daily milk consumption to all-cause mortality, coronary
heart disease and stroke
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reported on 37,049 cases of fatal and non fatal coronary
heart disease, and 10 cohorts including 564,717 subjects
reported on 39,352 cases of fatal and non fatal cases of
stroke. The median milk intake ranged from 0 to
850 mL/d. Adjustment for age, smoking, physical activ-
ity, total energy intake and BMI was done in nine studies
[6, 12–14, 17, 18, 21, 30, 35].
For all cause deaths, the risks reported by studies ranged
from 0.90 (95% CI: 0.81–1.00) to 1.15 (95% CI: 1.13–1.17)
(Fig. 2) [6, 15]. The SRR for all-cause deaths associated
with the consumption of 200 mL/d of milk was of 1.01
(95% CI: 0.96–1.06). The heterogeneity of results across
studies was considerable (I2 = 94%, p < 0.01). Excluding
Michaëlsson et al. [6] from the analysis resulted in a
SRR of 0.99 (95% CI: 0.95–1.03), with a somewhat
reduced heterogeneity (I2 = 63%, p < 0.01) (Additional
file 2: Table S2).
For fatal and non-fatal coronary heart diseases, relative
risks reported by studies ranged from 0.93 (95% CI:
0.85–1.01) to 1.15 (95% CI: 0.87–1.52) (Fig. 3) [10, 19].
The SRR of fatal and non-fatal coronary heart disease
associated with the consumption of 200 mL/ of milk was
1.01 (95% CI: 0.98–1.05). The heterogeneity of results
between studies was moderate (I2 = 16%, p = 0.30). Ex-
cluding Hu et al. [18] from the analysis did not alter the
results (Additional file 2: Table S2).
For fatal and non-fatal stroke, relative risks reported by
studies ranged from 0.66 (95%: 0.61–0.72) to 1.04 (95%
CI: 0.93–1.16) (Fig. 4) [13, 29]. The SRR of fatal and non-
fatal stroke associated with consumption of 200 mL/d of
milk was 0.91 (95% CI: 0.82–1.02). The heterogeneity of
results across studies was considerable (I2 = 92%, p < 0.01).
Stratified analyses restricted to men and adjustments for
age, BMI, total energy intake and physical activity did not
alter the estimates (Additional file 2: Table S2). The influ-
ences of individual studies with deviating results were
tested in a sensitivity analysis. For all-cause mortality,
exclusion of Michaëlsson et al. [6] did not influence the
SRR, nor did the exclusion of Hu et al. [18] for fatal and
non fatal coronary heart disease. Data from Abbott et al.
[16] were extracted from a figure, but excluding the study
did not influence the SRR.
No study reported results separately for skimmed and
for whole milk, except three [13, 17, 18]. Hu et al. [18]
compared the coronary heart disease risk of two or more
glasses/d milk versus never. They found a relative risk of
1.67 (95%CI: 1.14–1.90) for whole milk, and of 0.78
(95%CI: 0.63–0.96) for skimmed milk. Goldbohm et al.
[13] found no differences in mortality, ischemic heart
disease and stroke between whole and skimmed milk.
Larsson et al. [17] found no differences in risk of stroke
between whole milk and low fat milk.
Fig. 2 Relation between milk (per 200 mL/d) and all-cause mortality: dose-response meta-analyses of eleven prospective cohorts. Author names, year
of publication, and the size of the association per study; the horizontal lines indicate 95% confidence intervals. The last two columns contain the actual
estimated relative risks and 95% confidence intervals. On the x axis, a line is plotted through the relative risk = 1. The diamond at the bottom indicates
the summary relative risk with 95% confidence interval. Tests for heterogeneity and publication bias are mentioned at the bottom
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Despite the relatively small number of published data,
the Macaskill test and to some extent, the Egger test sug-
gested the presence of publication bias for all cause mor-
tality and fatal and non-fatal stroke (Additional file 2:
Table S2). Funnel plots are graphs in which the relative
risks reported by studies are plotted against the inverse
of relative risk variances. Relative risks of large size
studies have smaller variance and are located in the
upper part of the plots. Relative risks of small size
studies tend to be more variable and have a greater
variance. Small size studies are located in the lower
parts of the plots. The Additional file 2: Figure S1
shows an assymetry in the spread of relative risks in
the plot, with a gap in the right lower part of the plot.
These gaps suggest that a number of smaller size stud-
ies that found increased risks of all cause mortality
were not published. The Funnel plots for coronary
heart disease and for stroke are less indicative of publi-
cation bias.
The main results of the two studies that could not be
integrated in the meta-analysis were a relative risk of
coronary heart disease of 0.99 (95% CI: 0.71–1.38) in men
and of 1.01 (95% CI: 0.68–1.49) in women associated with
sometimes/often whole milk consumption relative to
never/rare milk consumption [42]. From a multivariate
model, Snowdon et al. [43] reported relative risks of 0.94
(p < 0.05) in men and of 1.11 (p > 0.05) in women when
comparing two glasses of milk a day versus none.
Discussion
Our meta-analysis of observational prospective studies
found no evidence for associations between milk con-
sumption and all-cause mortality, fatal and non fatal cor-
onary heart diseases and fatal or non fatal stroke. The
possibility of publication bias is however possible that
may have resulted in less published data suggesting in-
creased risk of all-cause mortality, and perhaps also of
stroke, associated with increasing milk consumption.
Our meta-analysis has several limitations. We could
not integrate Avalos et al. [42] and Snowdon et al. [43]
because a dichotomous variable was used for reporting
results. We did not take cardiovascular diseases as out-
come, because the definition of this condition was het-
erogeneous across studies. We also excluded two
studies because data specific to milk consumption were
not reported [36, 37]. For instance, the study of Fortes
et al. [36], that was included in Soedamah-Muthu et al.
[5], found an implausible relative risk of cardiovascular
mortality of 0.24 (95% CI: 0.07–0.86), associated with
consumption of milk and yoghurt together. Each study
expressed dairy consumption using different units
(pints, frequency/week, times/day, and servings/week),
Fig. 3 Relation between milk (per 200 mL/d) and fatal and non fatal coronary heart disease: dose-response meta-analyses of nine prospective
cohorts. Author names, year of publication, and the size of the association per study; the horizontal lines indicate 95% confidence intervals. The
last two columns contain the actual estimated relative risks and 95% confidence intervals. On the x axis, a line is plotted through the
relative risk = 1. The diamond at the bottom indicates the summary relative risk with 95% confidence interval. Tests for heterogeneity
and publication bias are mentioned at the bottom
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and assumptions about the volume of a serving had to
be made to convert values into mL/d.
The contradictory conclusions reached by the meta-
analysis of Soedamah-Muthu et al. [5] and by the Swedish
study [6] may be regarded as a reflect of the considerable
heterogeneity in results obtained by prospective studies
on milk consumption and all-cause mortality, coronary
heart disease and stroke. Several reasons may underlie the
heterogeneity in results obtained by studies, like selection
of subjects included in cohorts, the way milk consumption
was assessed, the types of milk consumed, and the adjust-
ments done. In most studies, a single measure of exposure
was done at baseline, which can lead to misclassification
of exposure during follow-up. Milk is never consumed
alone, but is part of a global nutritional and lifestyle be-
haviour. After decennia of promotion by governements
and by advertising campaigns, milk has acquired a
“healthy” image for the public, and has become considered
as being a natural component of a healthy diet. For ex-
ample, four prospective studies [10, 13, 33, 44] found
lower prevalences of smokers in milk drinkers, and two
[13, 44] found higher physical activity and education in
daily milk consumers. As a result, it can not be ruled out
that high milk consumption would be part of a health
conscious behavioural cluster, which will be difficult to
correct in multivariate analysis. Michaëlsson et al. [6]
found that intake of 200 mL/d of milk was associated with
a relative risk for all-cause mortality of 1.15 (95% CI:
1.12–1.19) in women and 1.03 (95% CI: 1.01–1.04) in
men. Such increased risk in women was never found in
other studies. In Michaëlsson et al. [6], current smoking
status increased with increasing milk consumption,
when other propective studies found the reverse, that is
lower smoking rates associated with greater milk con-
sumption [10, 13, 33, 44]. It could well be that in the
Swedish cohort, women who smoked tended to drink
more milk because of healthy virtues, like the preven-
tion of bone demineralisation. Osteoporotic fractures
are two to three times more frequent in women than in
men, and Sweden has one of the highest incidence of
osteoporotic fractures in the world [45]. It is also pre-
dicted that within the next 40 years or so, the annual
number of hip fractures in Sweden will double [46].
One could speculate that, considering the high public
awareness about osteoporotic fractures in Sweden, high
milk consumption would be part of a more general
behaviour intended to prevent osteoporotic fractures. If
women at higher risk of osteoporotic fracture because
they smoke or are physically inactive also drink more
milk, then high milk consumption could appear being
associated with a higher risk of cardiovascular events.
Multivariate analysis allows adjustment for potential
Fig. 4 Relation between milk (per 200 mL/d) and fatal and non fatal stroke: dose-response meta-analyses of ten prospective cohorts. Author names,
year of publication, and the size of the association per study; the horizontal lines indicate 95% confidence intervals. The last two columns contain the
actual estimated relative risks and 95% confidence intervals. On the x axis, a line is plotted through the relative risk = 1. The diamond at the bottom
indicates the summary relative risk with 95% confidence interval. Tests for heterogeneity and publication bias are mentioned at the bottom
Mullie et al. BMC Public Health  (2016) 16:1236 Page 6 of 8
confounders, but residual confounding may remain, due
to inaccurate measurement. Lastly, even if measurements
were perfect, multicollinearity is likely to threaten the
correct interpretation of multivariate models.
The meta-analysis of Soedamah-Muthu et al. [5] found
an inverse relationship between milk consumption and
cardiovascular disease, based on four prospective studies.
In three prospective studies, there was a heterogenous
definition of cardiovascular diseases going from only mor-
tality to coronary heart disease, stroke, cardiac arrest,
heart failure and sudden death. The study by Engberink et
al. [37], that was included in Soedamah-Muthu et al. [5],
is a poster on the Rotterdam Study presented at the an-
nual scientific meeting of the American Heart Association
in 2010, in which no risk estimates for milk consumption
and cardiovascular disease was reported. Results of the
Rotterdam Study were published in a further publication
by Praagman et al. [33], which we included in our meta-
analysis. However, Praagman et al. [33] reported results
for coronary heart disease and stroke, but not for cardio-
vascular disease.
Conclusion
Our meta-analysis of observational prospective studies
found no evidence of an association between milk con-
sumption and all-cause mortality, fatal and non fatal
coronary heart disease and fatal and non fatal stroke.
However, the possibility cannot be dismissed that a publi-
cation bias could lead to an underestimation of risks asso-
ciated with milk consumption.
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